AveXis Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Biotechs Bounce Off Bottom On Novartis Deal But Fade Later In The Day
Article By: Rod Raynovich
Monday, April 9, 2018 7:49 PM EDT
Normally this kind of M&A news would be an opportunity to load up on biotechs but technicals are still weak and crosscurrents from economic and macro news create a risk-off sentiment.
In this article: NVS, FBT, AGIO, AVXS Also: IBB, SGMO, XBI, BLUE, ONCE, CLLS, EDIT, NTLA, CRSP
Read
After Former Citron Short Target AveXis Gets Bought, Analyst Asks 'who's Next'
Article By: The Fly
Monday, April 9, 2018 11:25 AM EDT
AveXis shares are surging after the gene therapy researcher announced an agreement to be acquired by Novartis for $218 per share, or $8.7billion in cash. This comes two years after Citron Research made a short call of a AveXis $5 price target.
In this article: NVS, AVXS Also: BMRN, VYGR, BLUE, ONCE, RGNX
Read
AveXis Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, January 16, 2018 11:28 AM EDT
AveXis, Inc. today announced that it intends to offer and sell, subject to market conditions, up to $400 million of shares of its common stock in an underwritten public offering.
In this article: AVXS
Read
AveXis Inc.: Shares Spike On Positive Top Line Results For AVXS-101 Despite Q4 Loss
Article By: TickerTV
Friday, March 17, 2017 9:00 AM EDT
AVXS opened trading yesterday at $74.46, which was down from the previous day’s trading close of $74.88. Shares closed trading yesterday at $72.78 and spiked up after market to $81.50, equivalent to a 12% increase from the closing price.
In this article: AVXS
Read
AveXis Slides After Biogen, Ionis SMA Drug Approval
Article By: The Fly
Tuesday, December 27, 2016 2:12 PM EDT
Shares of AveXis are slipping after Biogen and Ionis Pharmaceuticals received FDA approval for Spinraza, their treatment for spinal muscular atrophy, or SMA.
In this article: BIIB, IONS, AVXS
Read

PARTNER HEADLINES

Latest Tweets for $AVXS

No tweets yet!